Shin Nishiumi
Overview
Explore the profile of Shin Nishiumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2605
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishiumi S, Yokoyama T, Ojima N
Rapid Commun Mass Spectrom
. 2024 Jan;
38(4):e9683.
PMID: 38212648
Rationale: Recently, metabolome analysis has been applied to a variety of research fields, but differences between batches or facilities can cause discrepancies in the results of such analyses. To resolve...
2.
Miyamoto S, Imai Y, Matsutani M, Nagai M, Yamanishi K, Kanazawa N, et al.
Dis Markers
. 2023 Nov;
2023:9013756.
PMID: 37946797
Dupilumab (DUP) is the first biological agent used treating atopic dermatitis (AD). Notwithstanding its high cost, the type of patient group for which the drug is effective remains unclear. In...
3.
Tuan V, Yahara K, Dung H, Binh T, Tung P, Tri T, et al.
Microb Genom
. 2023 Jul;
9(7).
PMID: 37410636
No abstract available.
4.
Takimoto Y, Tsubamoto H, Isono-Taniguchi R, Ueda T, Sakata K, Nakagawa K, et al.
Anticancer Res
. 2023 Apr;
43(5):1981-1984.
PMID: 37097657
Background/aim: Itraconazole, an antifungal drug, repolarizes pro-tumorigenic M2 tumor-associated macrophages to anti-tumorigenic M1-like phenotypes, thereby inhibiting the proliferation of cancer cells; however, the underlying mechanism remains unclear. Therefore, we investigated...
5.
Nishiumi S, Izumi Y, Hirayama A, Takahashi M, Nakao M, Hata K, et al.
Metabolites
. 2022 Feb;
12(2).
PMID: 35208210
In mass spectrometry-based metabolomics, the differences in the analytical results from different laboratories/machines are an issue to be considered because various types of machines are used in each laboratory. Moreover,...
6.
Tuan V, Yahara K, Dung H, Binh T, Tung P, Tri T, et al.
Microb Genom
. 2021 Nov;
7(11).
PMID: 34846284
Genome-wide association studies (GWASs) can reveal genetic variations associated with a phenotype in the absence of any hypothesis of candidate genes. The problem of false-positive sites linked with the responsible...
7.
Nakanishi T, Fukui H, Wang X, Nishiumi S, Yokota H, Makizaki Y, et al.
Cells
. 2021 Nov;
10(11).
PMID: 34831391
Although high-fat diet (HFD)-related dysbiosis is involved in the development of steatohepatitis, its pathophysiology especially in the small intestine remains unclear. We comprehensively investigated not only the liver pathology but...
8.
Isono R, Tsubamoto H, Ueda T, Takimoto Y, Inoue K, Sakata K, et al.
Anticancer Res
. 2021 Nov;
41(11):5477-5480.
PMID: 34732417
Background/aim: Itraconazole shows anticancer activity in various types of cancer but its underlying mechanism is unclear. We investigated the effect of itraconazole on membrane-associated lipids. Materials And Methods: To investigate...
9.
Luis G, Godfroid A, Nishiumi S, Cimino J, Blacher S, Maquoi E, et al.
Redox Biol
. 2021 May;
43:102006.
PMID: 34030117
Problem: Tumor recurrence is a major clinical issue that represents the principal cause of cancer-related deaths, with few targetable common pathways. Mechanisms by which residual tumors persist and progress under...
10.
Nakano R, Nishiumi S, Kobayashi T, Ikegawa T, Kodama Y, Yoshida M
Biomark Med
. 2020 Sep;
14(11):1009-1020.
PMID: 32940075
The aim of this study was to identify whether metabolite biomarker candidates for pancreatic cancer (PC) could aid detection of intraductal papillary mucinous neoplasms (IPMN), recognized as high-risk factors for...